A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 101,891 shares of VRTX stock, worth $45.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
101,891
Previous 85,612 19.01%
Holding current value
$45.9 Million
Previous $40.1 Million 18.09%
% of portfolio
0.11%
Previous 0.1%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$460.0 - $505.78 $7.49 Million - $8.23 Million
16,279 Added 19.01%
101,891 $47.4 Million
Q2 2024

Jul 16, 2024

BUY
$392.81 - $485.53 $1.4 Million - $1.74 Million
3,576 Added 4.36%
85,612 $40.1 Million
Q1 2024

Apr 15, 2024

BUY
$407.69 - $446.08 $2.88 Million - $3.15 Million
7,061 Added 9.42%
82,036 $34.3 Million
Q4 2023

Jan 30, 2024

BUY
$343.0 - $410.68 $9.39 Million - $11.2 Million
27,386 Added 57.55%
74,975 $30.5 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $12.7 Million - $13.7 Million
37,677 Added 380.12%
47,589 $16.5 Million
Q2 2023

Jul 21, 2023

BUY
$314.42 - $351.91 $42,132 - $47,155
134 Added 1.37%
9,912 $3.49 Million
Q1 2023

Apr 25, 2023

BUY
$283.23 - $323.1 $23,791 - $27,140
84 Added 0.87%
9,778 $3.08 Million
Q4 2022

Feb 01, 2023

SELL
$285.76 - $321.48 $1.01 Million - $1.13 Million
-3,525 Reduced 26.67%
9,694 $2.8 Million
Q3 2022

Oct 17, 2022

BUY
$273.83 - $305.53 $3.62 Million - $4.04 Million
13,219 New
13,219 $3.9 Million
Q2 2022

Jul 18, 2022

SELL
$234.96 - $292.55 $5.37 Million - $6.69 Million
-22,874 Closed
0 $0
Q1 2022

Apr 18, 2022

BUY
$221.42 - $260.97 $184,000 - $216,866
831 Added 3.77%
22,874 $6.15 Million
Q4 2021

Feb 08, 2022

BUY
$177.01 - $223.45 $3.9 Million - $4.93 Million
22,043 New
22,043 $5.37 Million
Q4 2020

Feb 10, 2021

SELL
$207.01 - $276.09 $1.43 Million - $1.91 Million
-6,920 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$255.65 - $303.1 $1.42 Million - $1.68 Million
-5,547 Reduced 44.49%
6,920 $1.9 Million
Q2 2020

Oct 13, 2020

BUY
$225.48 - $295.8 $2.81 Million - $3.69 Million
12,467 New
12,467 $3.63 Million
Q1 2019

Apr 30, 2019

SELL
$163.73 - $194.7 $1.2 Million - $1.43 Million
-7,325 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$151.91 - $192.21 $1.11 Million - $1.41 Million
7,325 New
7,325 $1.43 Million
Q4 2017

Jan 19, 2018

SELL
$137.28 - $155.55 $784,692 - $889,123
-5,716 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$148.13 - $162.24 $846,711 - $927,363
5,716
5,716 $887,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.